Skip to main content

What an Immune Study May Mean for Blood Pressure in MS

By MS Buddy ·

Summarized from Cardiovascular research, Oct 2026 · PubMed. AI-generated summary. Not medical advice.

Research by Masudur Rahman, Johannes Stegbauer and 16 colleagues at Heinrich-Heine-University, University Hospital Würzburg and 2 other institutions in Germany and China.

Key Takeaway

Immune cells from people with hard-to-control high blood pressure made blood pressure rise more in mice, but the study did not test people with MS.

Credibility
Interest
Share:2 min read

What They Found

Researchers put blood cells from people with hard-to-control high blood pressure into mice with weak immune systems. They gave the mice a substance that raises blood pressure. Blood pressure rose more in mice given cells from people with high blood pressure than in mice given cells from healthy people. The first group also had more trouble with blood vessels relaxing, which helps blood flow. A signal called TNF, made by certain immune cells, appeared to play a part: blocking it reduced the blood pressure rise in these mice.

Who Should Care and Why

People with MS and their caregivers may find this study useful because it shows one way immune cells might affect blood pressure. It does not show that MS causes high blood pressure or that the same process happens in people with MS. If you track your blood pressure, keep sharing the readings with your care team, especially if they stay high despite treatment. Think of this study as a clue for researchers, not a new step to add to your daily care. Do not change an MS or blood pressure treatment because of these results; ask your clinician about any concerns.

Important Considerations

The main tests were done in mice, so the results may not apply to people. The donated cells came from people with hard-to-control high blood pressure, not from people selected for having MS. Blocking TNF helped the mice, but this study did not show that a TNF-blocking treatment is safe or helpful for people with MS.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in Cardiovascular research by et al.. Reproduced from the PubMed record.

Preclinical studies suggest a pivotal role of adaptive immunity, particularly T cells, in hypertension. However, due to the multifactorial pathogenesis, there is still no definitive evidence for a causal role of T cells in the development of hypertension in humans. We sought to determine whether T cells from patients with treatment-resistant hypertension (TRH) directly modulate blood pressure and vascular function in vivo. Peripheral blood mononuclear cells (PBMCs) from TRH patients and healthy controls (HC) were adoptively transferred into immunodeficient NSG-(KbDb)^null mice. Hypertension was induced by angiotensin II infusion for 14 days and monitored continuously by radiotelemetry. Following T cell engraftment, blood pressure was assessed at baseline and during AngII infusion in both groups of recipient mice. At baseline, systolic blood pressure did not differ between both groups. However, mice receiving TRH-PBMCs developed a significantly higher systolic blood pressure following AngII compared with HC-PBMC recipients. Endothelial dysfunction in isolated perfused kidneys was more pronounced in AngII-challenged TRH-PBMC recipients compared to HC-PBMC recipients. TRH-PBMC recipients displayed elevated effector memory CD4+ T cells and Th17 frequencies in spleen and kidney, along with markedly increased renal expression of human T cell-derived TNF. Overnight incubation of mouse aortic rings with human TNF induced endothelial dysfunction, indicating a causal role of T cell-derived TNF. As a proof of concept, TNF inhibition attenuated AngII-induced hypertension in TRH-PBMC-engrafted mice. T cells from patients with treatment-resistant hypertension promote an exaggerated hypertensive response and endothelial dysfunction in PBMC-engrafted humanized mice, promoted by TNF-mediated mechanisms. These findings provide evidence that T cell-derived TNF may contribute to the pathogenesis of human hypertension.

Explore more research

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

MS and Anxiety: A Better Way to Spot Worry About the Future

11/8/2026

A study finds a short survey may help spot worry about the unknown in people with MS. Learn what it

Read More
MS Hospital Stays: Why Mental Health Checks Matter

11/9/2026

A U.S. study found anxiety, depression, and pain more often in MS hospital stays. Learn why asking f

Read More
MS and Suicide Risk: What to Share With Your Care Team

11/7/2026

A study of 360 people with MS links past suicide attempts with depression, smoking, and childhood ha

Read More
Could Voice Checks Help Track MS Changes From Home?

11/4/2026

Could a short voice recording help track MS changes? Learn why speech-checking tools show promise fo

Read More
Could MS Brain Scans Help Predict Future Thinking Changes?

11/4/2026

A four-year MS study links the condition of nerve coating in brain lesions with later thinking speed

Read More
Can MRI Scans Help Tell a True MS Relapse From a Flare?

11/3/2026

A study of two MS medicines found MRI scans may help confirm relapses and clarify treatment differen

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.